CD8A and melanoma: Furthermore, treatment of tumor-bearing mice with a monoclonal anti-Gal1 antibody led to normalization of the tumor vasculature in Lewis lung carcinoma (LLC) and B16 melanomas and an elevation of the number of CD8+ T cells in the tumor microenvironment [6–8, 18].